Workflow
Medifast(MED)
icon
Search documents
Medifast(MED) - 2019 Q2 - Earnings Call Transcript
2019-08-04 19:18
Medifast, Inc. (NYSE:MED) Q2 2019 Earnings Conference Call August 1, 2019 4:30 PM ET Company Participants Katie Turner - ICR Dan Chard - CEO Tim Robinson - CFO Conference Call Participants Linda Weiser - DA Davidson Steph Wissink - Jefferies Doug Lane - Lane Research Operator Hello, and welcome to the Medifast Second Quarter Fiscal 2019 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to your host today, Katie Turner. P ...
Medifast(MED) - 2019 Q2 - Quarterly Report
2019-08-02 20:02
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3714405 (State or other jurisdi ...
Medifast(MED) - 2019 Q1 - Quarterly Report
2019-05-02 20:20
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10‑Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 13‑3714405 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 00 ...
Medifast(MED) - 2018 Q4 - Annual Report
2019-03-01 22:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-31573 Medifast, Inc. (Exact name of registrant as specified in its charter) Delaware 13-3714405 (State or other jurisdiction of incorporation o ...